ASPEN PHARMACARE HOLDINGS LIMITED – Grant and Acceptance of Share Awards by Directors, Prescribed Officers and The Company Secretary of Aspen and a Director and the Company Secretary of a Major Subsidiary of Aspen

Grant and Acceptance of Share Awards by Directors, Prescribed Officers and The Company Secretary of Aspen and a Director and the Company Secretary of a Major Subsidiary of Aspen

ASPEN PHARMACARE HOLDINGS LIMITED (“Aspen” or “the Company”) (Incorporated in the Republic of South Africa) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94

GRANT AND ACCEPTANCE OF SHARE AWARDS BY DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY OF ASPEN AND A DIRECTOR AND THE COMPANY SECRETARY OF A MAJOR SUBSIDIARY OF ASPEN

In compliance with paragraphs 6.77 to 6.85 of the JSE Limited Listings Requirements, shareholders are advised of the following awards of securities under the Aspen Management Deferred Incentive Scheme to directors, a prescribed officer and the company secretary of the Company, and to a director and the company secretary of Pharmacare Limited t/a Aspen Pharmacare, a major subsidiary of the Company.

Director : Stephen Bradley Saad Date of transaction : 5 November 2026 Nature of transaction : Off-market award and acceptance of deferred incentive shares (vesting after 3, 4 & 5 years) Number of securities : 64,797 Grant price* : R161.73 Deemed value of transaction : R10,479,456.82 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes

Director : Sean Matthew Capazorio Date of transaction : 4 November 2026 Nature of transaction : Off-market award and acceptance of deferred incentive shares (vesting after 3, 4 & 5 years) Number of securities : 29,726 Grant price* : R161.73 Deemed value of transaction : R4,807,511.67 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes

Name : Lorraine Angela Hill Date of transaction : 4 November 2026 Nature of transaction : Off-market award and acceptance of deferred incentive shares (vesting after 3, 4 & 5 years) Number of securities : 28,976 Grant price* : R161.73 Deemed value of transaction : R4,686,216.04 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes

Name : Raeesa Khan Date of transaction : 4 November 2026 Nature of transaction : Off-market award and acceptance of deferred incentive bonus shares (vesting after 3, 4 & 5 years) Number of securities : 6,459 Grant price* : R161.73 Deemed value of transaction : R1,044,597.92 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes

DIRECTOR OF A MAJOR SUBSIDIARY OF THE COMPANY

Director : Heinz Louis Schütte Date of transaction : 5 November 2026 Nature of transaction : Off-market award and acceptance of deferred incentive shares (vesting after 3, 4 & 5 years) Number of securities : 9,443 Grant price* : R161.73 Deemed value of transaction : R1,527,192.78 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes

COMPANY SECRETARY OF A MAJOR SUBSIDIARY OF THE COMPANY

Name : Karen Teresa Naidoo Date of transaction : 5 November 2026 Nature of transaction : Off-market award and acceptance of deferred incentive bonus shares (vesting after 3, 4 & 5 years) Number of securities : 1,776 Grant price* : R161.73 Deemed value of transaction : R287,228.04 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes

*based on the Aspen 3-day VWAP on 2 November 2026

Sponsor Investec Bank Limited Date: 09/11/2026 05:40:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (‘JSE’). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.